Avutometinib potassium is a potent RAF/MEK inhibitor that effectively prevents MEK phosphorylation by ARAF, BRAF, and CRAF through the formation of dominant negative RAF-MEK complexes. This compound exhibits significant anti-proliferative activity across various tumor cell lines, particularly those with KRAS mutations, including pancreatic ductal adenocarcinoma (PDAC) cell lines. In vivo studies demonstrate that Avutometinib potassium inhibits tumor growth and enhances survival in mouse models of KRAS and p53 mutant pancreatic cancer. It holds potential for research in low-grade serous ovarian carcinoma and other oncogenic conditions involving the RAF/MEK pathway.
Avutometinib potassium is a potent RAF/MEK inhibitor that effectively prevents MEK phosphorylation by ARAF, BRAF, and CRAF through the formation of dominant negative RAF-MEK complexes. This compound exhibits significant anti-proliferative activity across various tumor cell lines, particularly those with KRAS mutations, including pancreatic ductal adenocarcinoma (PDAC) cell lines. In vivo studies demonstrate that Avutometinib potassium inhibits tumor growth and enhances survival in mouse models of KRAS and p53 mutant pancreatic cancer. It holds potential for research in low-grade serous ovarian carcinoma and other oncogenic conditions involving the RAF/MEK pathway.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
